Vitro Biopharma

Description

• Vitro Biopharma, a publicly traded biotechnology firm (OTCQB:VODG), develops technology and products derived from adult stem cells and is currently focused on mesenchymal stem cells (MSCs). These adult stem cells were originally discovered in bone marrow but are now found in several tissues including adipose tissue, umbilical cord blood, teeth, etc. MSCs have numerous applications in treatment of a variety of medical conditions, including injuries or diseases of the joints, promoting transplantation of hematopoeitic stem cells used to treat various blood and autoimmune diseases, heart, kidney, liver and lung failure, MS, stroke, cancer, hearing loss and various other regenerative medicine applications. MSCs may be derived from an individual patient, expanded and then transplanted back to that patient to treat injury or disease through regeneration or repair of specific cells. Vitro manufactures and distributes to global markets a series of products for use by scientists and companies developing clinical applications of MSCs. Our products include: a) Human MSCs and derivatives, especially fluorescent labelled MSCs, b) Tools for iPSC research including and human MSCs expressing Oct3/4. Vitro also owns proprietary technology for generation of iPSCs from MSCs and other adult stem cells. c) MSC-GroTM Brand of stem cell media optimized for growth and differentiation of MSCs, d)Bioluminescent assays for determination of stem cell quality, potency and toxicity.
• 

  Headquarters:4621 Technology Drive , Golden, Colorado, United States

  More
• 

  Phone Number: +1 303-999-2130

• 

  Website: https://www.vitrobiopharma.com

• 

  Employees:8

• 

  Revenue:$1 - 10M

• 

  Legal Name:Vitro Biopharma

• Vitro Biopharma's Social Media

  
• Is this data correct?

• |  NAICS Code: 325414  |

  Show More